These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8272199)

  • 1. Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia.
    Murialdo G; Fonzi S; Torre F; Costelli P; Solinas G; Tosca P; Di Paolo E; Porro S; Zerbi F; Polleri A
    Neuropsychobiology; 1993; 28(4):177-83. PubMed ID: 8272199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
    Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia.
    Murialdo G; Zerbi F; Filippi U; Tosca P; Fonzi S; Di Paolo E; Costelli P; Porro S; Polleri A; Savoldi F
    Neuropsychobiology; 1990-1991; 24(3):129-34. PubMed ID: 1983729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
    Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
    J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
    Peñalva A; Muruais C; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men.
    Coiro V; Volpi R; Bertoni P; Finzi G; Marcato A; Caiazza A; Colla R; Giacalone G; Rossi G; Chiodera P
    Gerontology; 1992; 38(4):217-22. PubMed ID: 1358762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin hypoglycemia test and releasing hormone (corticotropin-releasing hormone and growth hormone-releasing hormone) stimulation in patients with pituitary failure of different origin.
    Stalla GK; Losa M; Oeckler R; Müller OA; von Werder K
    Horm Res; 1988; 29(5-6):191-6. PubMed ID: 2851521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high altitude on hypothalamic-pituitary secretory dynamics in men.
    Ramirez G; Herrera R; Pineda D; Bittle PA; Rabb HA; Bercu BB
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):11-8. PubMed ID: 7641401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Barini A
    J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein.
    Riedel W; Schlapp U; Leck S; Netter P; Neeck G
    Ann N Y Acad Sci; 2002 Jun; 966():483-90. PubMed ID: 12114308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
    Borges MH; Castro RC; Kater CE; Lengyel AM
    Braz J Med Biol Res; 1993 Nov; 26(11):1191-200. PubMed ID: 7907904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep and the hypothalamo-pituitary-adrenocortical system.
    Steiger A
    Sleep Med Rev; 2002 Apr; 6(2):125-38. PubMed ID: 12531148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.